Shunichi Kitajima
Directeur/Bestuurslid bij TRANS GENIC INC.
Vermogen: 34 890 $ op 30-04-2024
Profiel
Shunichi Kitajima is currently the Director & GM-Contract Research Organization at Trans Genic Inc., the Director at New Drug Research Center Inc., and the Director at Biosafety Research Center, Inc. He previously worked as the Director at GeneticLab Co., Ltd.
from 2017 to 2022.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
TRANS GENIC INC.
0.14% | 31-03-2023 | 23 069 ( 0.14% ) | 34 890 $ | 30-04-2024 |
Actieve functies van Shunichi Kitajima
Bedrijven | Functie | Begin |
---|---|---|
TRANS GENIC INC. | Directeur/Bestuurslid | 01-06-2015 |
New Drug Research Center Inc.
New Drug Research Center Inc. Miscellaneous Commercial ServicesCommercial Services New Drug Research Center Inc. engages in the research, development and support of medical products, medical equipment, and chemical substances. It performs drugs and food clinical trials and tests compatible with good clinical practice (GCP). The company was founded in April 2013 and is headquartered in Tokyo, Japan. | Directeur/Bestuurslid | 01-04-2013 |
Biosafety Research Center, Inc.
Biosafety Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Trans Genic Inc., Biosafety Research Center, Inc. is a safety test contractor that supports pharmaceuticals and food development. The private company is based in Iwata, Japan. The Japanese company is entrusted with clinical tests in animal species that are commonly used and analysis of subject substances and biological components in biological samples. The company offers physical properties analysis, spectrum measurement of the sample, water, ash, and content analysis. The company has developed several mouse models for stress visualization and gene visualization of oxidative stress. The company also conducts reproductive toxicity tests to examine the effects of subject substances on the reproductive function of the parent generation and the occurrence of the next generation. | Directeur/Bestuurslid | 01-03-2018 |
Eerdere bekende functies van Shunichi Kitajima
Bedrijven | Functie | Einde |
---|---|---|
GeneticLab Co., Ltd.
GeneticLab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services GeneticLab Co., Ltd. provides gene expression analysis and pathological diagnostic services. It also engages in medical care development services. The company was founded on September 1, 2000 and is headquartered in Sapporo, Japan. | Directeur/Bestuurslid | 01-01-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Trans Genic Inc. | |
New Drug Research Center Inc.
New Drug Research Center Inc. Miscellaneous Commercial ServicesCommercial Services New Drug Research Center Inc. engages in the research, development and support of medical products, medical equipment, and chemical substances. It performs drugs and food clinical trials and tests compatible with good clinical practice (GCP). The company was founded in April 2013 and is headquartered in Tokyo, Japan. | Commercial Services |
Biosafety Research Center, Inc.
Biosafety Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Trans Genic Inc., Biosafety Research Center, Inc. is a safety test contractor that supports pharmaceuticals and food development. The private company is based in Iwata, Japan. The Japanese company is entrusted with clinical tests in animal species that are commonly used and analysis of subject substances and biological components in biological samples. The company offers physical properties analysis, spectrum measurement of the sample, water, ash, and content analysis. The company has developed several mouse models for stress visualization and gene visualization of oxidative stress. The company also conducts reproductive toxicity tests to examine the effects of subject substances on the reproductive function of the parent generation and the occurrence of the next generation. | Commercial Services |
GeneticLab Co., Ltd.
GeneticLab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services GeneticLab Co., Ltd. provides gene expression analysis and pathological diagnostic services. It also engages in medical care development services. The company was founded on September 1, 2000 and is headquartered in Sapporo, Japan. | Commercial Services |